article thumbnail

Compounding Pharmacies Market Caters To Key Regional Health Care Issues

Pharmacy Times

Pharmacists can leverage patient medical history for formulating effective drugs, and patients can also benefit from single dosage, greater efficacy, and affordability of compounded medications.

article thumbnail

Evaluate 503B Facilities for Outsourced Compounds

Pharmacy Times

Complete due diligence before selecting a compounding pharmacy and establishing an outsourcing relationship.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Stakeholders Urge FDA to Protect Access to Compounded Hormone Therapies

Pharmacy Times

Prescribers signed a letter expressing concerns about recommendations for restrictions on compounded hormones, which millions of women and other patient populations rely on.

article thumbnail

Continuing Education for Pharmacy Technicians Essential for Safe, Sterile Compounding

Pharmacy Times

Research indicates that poor technique or failure to follow up-to-date standards and protocols could lead to injury or even death of patients who need compounded medications.

article thumbnail

UTSA researchers to develop compounds for GBM tumours

Pharmaceutical Technology

A researchers’ team from the University of Texas at San Antonio’s (UTSA) Department of Chemistry and its partners are developing compounds to treat Glioblastoma multiforme (GBM) tumours. The post UTSA researchers to develop compounds for GBM tumours appeared first on Pharmaceutical Technology.

article thumbnail

Novel Compounds Show Potential for Treating Anxiety Disorders With Fewer Adverse Effects

Pharmacy Times

Lead compounds may lower the risk of abuse and other adverse effects compared with other drugs currently being evaluated for mental health disorders, such as MDMA.

article thumbnail

USP Expert Discusses Revisions to Compounding Chapters ,

Pharmacy Times

Brian Serumaga, PhD, of US Pharmacopeia (USP) discusses the revisions to compounding chapters and and the resources available to help pharmacists update their practices.

article thumbnail

The discovery of a new and compounding cybersecurity threat to pharmacies

Pharma Phorum

The post The discovery of a new and compounding cybersecurity threat to pharmacies appeared first on.

article thumbnail

Magic mushroom compound matches antidepressant in clinical trial

Pharma Phorum

The active compound in magic mushrooms – psilocybin – seems to be at least as effective as a commercially-available antidepressant in a phase 2 trial, and may work more quickly. . The post Magic mushroom compound matches antidepressant in clinical trial appeared first on.

article thumbnail

AI company zeros in on compounds to treat addiction by rewiring the brain

PharmaVoice

GATC Health is driving a novel approach it believes could work for several major neurological conditions

article thumbnail

Leading pharmaceutical compounding companies in contract marketing

Pharmaceutical Technology

Pharmaceutical compounding is a method of preparing personalised medications for patients by mixing the individual ingredients in the exact strength and dosage form required by the patient. Discover the top pharmaceutical compounding companies in contract marketing.

article thumbnail

Rising Demand for Customized Medication To Transform Compounding Pharmacies Market Outlook

Pharma Mirror

Compounding pharmacies, which involve the preparation and selling of prescribed medicines are gaining massive popularity across the healthcare sector owing to the rising awareness regarding the benefits of compounded medications.

article thumbnail

Merck attempts to reduce levels of carcinogenic compounds in diabetes drugs

Pharmafile

Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found in its popular type 2 diabetes drugs. These compounds are naturally found in fresh fruits and vegetables, grilled meats and fish, and in water and the air.

article thumbnail

Investigators Identify Compound That May Halt Infections, Including Common Cold, COVID-19

Pharmacy Times

Findings from the University of British Columbia’s Life Sciences Institute show a potential path toward antiviral treatments that could be used against many different pathogens.

article thumbnail

Pharmacists, Technicians Can Work to Mitigate Risks of Pharmacy Compounding

Pharmacy Times

A more comprehensive body of regulations is required to achieve consistency and safety for patients.

article thumbnail

Leading innovators in isotropically modified heterocyclic compounds for the pharmaceutical industry

Pharmaceutical Technology

In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on I nnovation in Pharmaceuticals: Isotropically modified heterocyclic compounds.

article thumbnail

Psychoactive compound to advance research in treatment of depressive disorders

Pharma Times

Lucid-PSYCH is a psychoactive compound potentially viable for the treatment of major depressive disorders

article thumbnail

Reaxys User Day 2022: Researcher secrets in the spotlight

Elsevier

We spoke with senior director Ivan Krstic about how Reaxys is turning data into actionable insights to better understand the competitive landscape, design novel compounds, and generally accelerate synthetic chemistry.

article thumbnail

Magic mushroom compound psilocybin shows ‘promise’ in depression

Pharma Times

Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting

article thumbnail

Sep 16, Compound for Lidocaine 3% in 120ML Calamine Lotion-How many milligrams of lidocaine powder must be added to the calamine lotion?

Pharmacy Tech Resources

A physician has requested a compound for lidocaine 3% in 120mL calamine lotion. How many miligrams of lidocaine powder must be added to the calamine lotion

article thumbnail

Reaxys User Day 2022: Sharing insights and tips for streamlining the chemist workflow

Elsevier

These user presentations covered successful approaches when facing key challenges around identifying emerging competitors, assessing bioactivity of compounds, obtaining and customising retrosynthesis routes, and much more. Designing novel and effective compounds.

article thumbnail

Technicians Play Key Roles in Health Systems

Pharmacy Times

Seventeen percent work in hospital settings, including compounding, inpatient, medication reconciliation, and outpatient areas.

article thumbnail

Pharmacy Leaders Can Establish Successful 503B Relationships

Pharmacy Times

Key questions to ask when deciding whether compounding facilities are the right fit.

article thumbnail

Developing Standardized Concentrations, Overcoming Barriers

Pharmacy Times

Simplifying processes reduces errors in compounding, IV pump programming, and physician order entry.

article thumbnail

Nobiletin May Inhibit Tumor Activity in Cholangiocarcinoma

Pharmacy Times

A compound often found in citrus fruits, nobiletin, could be a less toxic and more effective treatment for cholangiocarcinoma.

article thumbnail

NervGen Pharma sets sights on trial for spinal-cord injury treatment

Outsourcing Pharma

The company plans to launch a Phase Ib/II study of its compound NVG-291 in collaboration with researchers at Northwestern Universityâs Shirley Ryan AbilityLab.

article thumbnail

Global Generic Drug Market Forecast to Hit $531.8 Billion by 2028

Pharmacy Times

Study results show a compound annual growth rate of 5.2% from $392.4 billion in revenue in 2021.

article thumbnail

Causeway Therapeutics raises £8.75m for tennis elbow research

Pharmafile

University of Glasgow spin-out Causeway Therapeutics has announced that it has raised £8.75m from investors, which will fund an international phase 2 clinical trial studying its lead compound TenoMIRä.

article thumbnail

Owlstone Medical Publishes Data on Biomarkers for Liver Disease Detection

Outsourcing Pharma

A study has shown that the use of exhaled volatile organic compounds (VOCs) can be used as biomarkers for differentially identifying liver disease on breath.

article thumbnail

USP Will Become Enforceable for Facilities Once Revisions of , Approved

Pharmacy Times

Kevin Straughn, PharmD, clinical pharmacist at Duke Regional Hospital, said once the 2 compounding chapters, and become enforceable, there will be a 6-month grace period before USP becomes enforceable.

article thumbnail

FDA grants approval to Beckley Psytech’s short-acting psychedelic trial

Pharmafile

BPL-003 is a novel synthetic formulation of the psychedelic compound 5-MeO-DMT (Mebufotenin) and is administered intranasally via an FDA-approved delivery device.

article thumbnail

The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development

Pharmaceutical Technology

Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. In reality, a BCS Class IV compound could have F abs of 80% and high solubility at pH 6.5,

article thumbnail

US FDA approves Incyte’s merkel cell carcinoma therapy

Pharmaceutical Technology

It is also being assessed in other tumour types and along with other Incyte pipeline compounds. We continue to study the potential of Zynyz in additional tumour types and in combination with other Incyte pipeline compounds.”

article thumbnail

Novel cancer therapeutic synthesised by Stanford researchers

European Pharmaceutical Review

Research published in the journal Nature Chemistry , shows how researchers from Stanford University in the US uncovered a promising new method to synthetically manufacture the compound tigilanol tiglate, named EBC-46, which could offer targeted medicine for cancer and other diseases.

article thumbnail

NICE recommends gene silencing therapy for porphyria patients on NHS

Pharma Times

Givlaari uses ‘gene silencing’ RNA interference technology, to target the production of pathogenic compounds in people AHP

article thumbnail

Eli Lilly signs $40m licensing deal with Confo Therapeutics over neuropathic pain treatment

Pharmafile

US-based pharmaceutical company Eli Lilly has signed a small licensing deal with Belgian start-up Confo Therapeutics to allow them access to the rights for a group of compounds headed by CFTX-1554.

article thumbnail

Pharma can now track the most relevant patent info – fast and at scale

Elsevier

It’s essential to combine the information coming from both text and images because sometimes a compound is mentioned in an image but not in the text.

article thumbnail

Promising first-in-human study results for orally inhaled antibiotic

European Pharmaceutical Review

The novel macrocycle compound achieved high inhibiting concentrations in the lung airways of participants. Spexis’ novel macrocycle compound. Analyses of preliminary, blinded data showed that the macrocycle compound was well tolerated at all dose levels.

article thumbnail

Handling HPAPIs safely – what does it take?

European Pharmaceutical Review

” Highly potent APIs are pharmacologically and biologically active compounds at low doses. The compounds require special handling due to their cytotoxicity in the NCEs and investigational new drug applications (INDs).

article thumbnail

Mass spectrometry software can link different data types

European Pharmaceutical Review

Integrative workflows combining IMS data from LC-MS and MS imaging enable large-scale metabolomics and lipidomics research by spectral preprocessing, feature detection and various options for compound identification for thousands of samples in parallel.

article thumbnail

Priothera announces first patients enrolled in pivotal MO-TRANS global Phase 2b/3 study with mocravimod as an adjunctive and maintenance therapy for patients with Acute Myeloid Leukemia (AML) undergoing allogeneic Hematopoietic Cell Transplant (HCT)

Pharmafile

article thumbnail

Novel Cell Cytometers: Need of the Hour

Roots Analysis

In fact, high throughput flow cytometers are used for phenotypic screening, antibody screening, lead optimization and multiplex compound profiling, enabling the measurement of several endpoints at once.

article thumbnail

Canadian and US developers to trial psychedelic medicines in UK

European Pharmaceutical Review

PharmAla, based in Toronto has developed a 3,4-Methyl​enedioxy​methamphetamine (MDMA)-based drug compound to treat social anxiety in adults with ASD, and is the only manufacturer of clinical grade MDMA in North America.